Navigation Links
Bobbi Drais Promoted to Vice President, Regulatory Affairs for HEALTHPOINT, Ltd.
Date:5/7/2009

FORT WORTH, Texas, May 7 /PRNewswire/ -- HEALTHPOINT, Ltd., a DFB Pharmaceuticals, Inc. company, has announced the promotion of Bobbi Drais to Vice President of Regulatory Affairs. Ms. Drais, with 15 years of regulatory experience, was most recently Senior Director of Regulatory Affairs for the company.

Since joining Healthpoint in 2003, Ms. Drais has achieved landmark regulatory success for DFB and Healthpoint. Ms. Drais initially established the regulatory department for Healthpoint. She and her team secured new drug approval (NDA) and marketing authorization approval (MAA) for ATRALIN(TM) (tretinoin) Gel in the US and Europe, respectively, the first Healthpoint proprietary product to achieve such approval. Ms. Drais was also instrumental in gaining regulatory approval of Collagenase SANTYL(R) Ointment in Canada.

"With Bobbi at the helm of all regulatory functions, I have great confidence that Healthpoint can seamlessly continue along its trajectory of success," said Travis E. Baugh, President of Healthpoint. "We're fortunate to have such a seasoned professional in this role as we navigate the regulatory waters. We count on her tremendously."

Prior to joining the DFB family of companies, Ms. Drais was Regulatory Affairs Manager for Galderma Laboratories, LP, Carrington Laboratories, Inc. and Smith & Nephew, Inc.

Ms. Drais graduated from Messiah College in Grantham, Pa., with a Bachelor of Science degree in biology. She also earned a Master of Science degree in microbiology from the University of South Florida in Tampa, Fla. Ms. Drais maintains memberships in the Regulatory Affairs Professional Society and the Drug Information Association, and she holds a Regulatory Affairs Certification (RAC).

Since 1992, HEALTHPOINT has been dedicated to innovative technologies for the prevention and treatment of acute, chronic and burn-related wounds. The company is presently focused on the research and development of novel biologics and pharmaceuticals intended to improve clinical and quality of life outcomes. Currently marketed products include: Collagenase SANTYL(R) Ointment, OASIS(R) Wound Matrix, HYDROFERA BLUE(R) Bacteriostatic Wound Dressings, and SURGICEPT(R) Waterless Surgical Hand Antiseptic. HEALTHPOINT is also committed to advancing the care and treatment of wounds through support of industry leading continuing education from THE WOUND INSTITUTE(R). To learn more about this comprehensive and award winning educational resource, please visit TheWoundInstitute.com(R). HEALTHPOINT is a DFB Pharmaceuticals, Inc. affiliate company, and is based in Fort Worth, Texas. For more information, visit the HEALTHPOINT website at www.healthpoint.com.


'/>"/>
SOURCE HEALTHPOINT, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bobbi Brown Cosmetics Creates Limited-Edition Lip Palette in Partnership with The Heart Truths Red Dress Collection 2008 Fashion Show
2. Bobbi Brown Cosmetics Creates Limited-Edition Red Lip Palette in Partnership With The Heart Truths 2008 Red Dress Collection
3. CWs 7th Heaven Actress Mackenzie Rosman to Visit Birmingham Area High School to Honor Cystic Fibrosis Foundation Fundraising
4. Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis
5. Khanna Institute Supports Oaks Christian School's Annual Fundraiser
6. Maryland Mystery Author Organizes Fundraising Ride for Rare Neurological Disorder
7. West Coast Bank Sponsors Reach the Beach Cycling Fundraiser to Support the American Lung Association
8. Country Star Phil Vassar to Perform at Transplantation Fundraiser
9. American Airlines Applauded for Its Fundraising to Support Susan G. Komen for the Cure(R), Promise Grant to The University of Texas M. D. Anderson Cancer Center
10. Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign
11. Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 05, 2016 , ... TransWipe Volume 3 is a set of 30 professional ... TransWipe preset between two video clips to instantly add a unique transition to any ... customizable color and orientation options. TransWipe Volume 3 is a Final Cut Pro X ...
(Date:5/5/2016)... ... 2016 , ... The U.S. Food and Drug Administration today ... submit their products through an arduous federal approval process. The rules, which treat ... market since February 15, 2007. That would essentially ban 99 percent of all ...
(Date:5/5/2016)... ... May 05, 2016 , ... Spring Fertility , the ... and with egg freezing, today announced the grand opening of its first location ... care, Spring Fertility offers both fertility preservation (egg, sperm, embryo, and testicular and ...
(Date:5/5/2016)... , ... May 05, 2016 , ... Derrin Doty Group ... families of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring ... year local girl who died suddenly due to complications from the flu, that they ...
(Date:5/5/2016)... ... May 05, 2016 , ... A recent survey by the ... challenges in getting employees to understand and use the free preventive care benefits available ... leading non-profit business groups of large, self-insured public and private employers, MBGH found that ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... -- Research and Markets has announced the addition of ... Markets"  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... current Positron Emission Tomography (PET) scanner and cyclotron install base ... France , Germany , ... and the United Kingdom . Along with ...
(Date:5/5/2016)... 5, 2016 Research ... "Europe Systemic Lupus Erythematosus Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Europe Systemic Lupus Erythematosus Market and Competitive ... into Systemic Lupus Erythematosus pipeline products, Systemic ...
(Date:5/4/2016)... ZIONA, Israel , May 4, 2016 ... BVXV) announced today that BiondVax,s CEO, Dr. Ron Babecoff ... in New York City . ... 10:30am at Pioneers 2016, a conference presented by Joseph ... Palace Hotel. The BiondVax presentation that Dr. Babecoff ...
Breaking Medicine Technology: